NCT02031510View on ClinicalTrials.gov

Dexmedetomidine in Transversus Abdominis Plane Block for Laparoscopic Cholecystectomy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

March 31, 2015

Conditions
Elective Laparoscopic Cholecystectomy
Interventions
DRUG

placebo

transversus abdominis plane block with saline 0.9%

DRUG

bupivacaine

transversus abdominis plane block bupivacaine 0.25%

DRUG

bupivacaine-dexmedetomidine

transversus abdominis plane block with bupivacaine 0.25% with dexmedetomidine 1 µg Kg-1

Trial Locations (2)

31592

King Fahd Hospital of Dammam University, Khobar

31952

Dammam University, Khobar

All Listed Sponsors
collaborator

Mansoura University

OTHER

lead

Imam Abdulrahman Bin Faisal University

OTHER

NCT02031510 - Dexmedetomidine in Transversus Abdominis Plane Block for Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter